Optimal decision indices for R\&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index
DOI10.1016/J.EJOR.2006.01.011zbMATH Open1111.90329OpenAlexW1966841982MaRDI QIDQ856299FDOQ856299
Publication date: 7 December 2006
Published in: European Journal of Operational Research (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.ejor.2006.01.011
statistical decision theorygittins indexPearson indexproject prioritizationresearch and development in pharmaceutical industry
Management decision making, including multiple objectives (90B50) Production models (90B30) Stochastic models in economics (91B70)
Cites Work
Cited In (5)
- REAL OPTIONS AND THE EVALUATION OF RESEARCH AND DEVELOPEMENT PROJECTS IN THE PHARMACEUTICAL INDUSTRY : A CASE STUDY(Special Issue on Theory, Methodology and Applications in Financial Engneering)
- Evaluating pharmaceutical R\&D under technical and economic uncertainty
- Genetic algorithm-based multi-criteria project portfolio selection
- Index policy for multiarmed bandit problem with dynamic risk measures
- Constructing strategies in strategic planning: a decision support evaluation model
This page was built for publication: Optimal decision indices for R\&D project evaluation in the pharmaceutical industry: Pearson index versus Gittins index
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q856299)